Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer
Clinical trial NCT00652691 · COMPLETED
Trial details
- NCT number
- NCT00652691
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 1998-08-01
- Primary completion
- 2002-06-05
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.